79388821

Information

• Trademark
• 79388821

• Source

• Serial Number

  79388821

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 35 - Advertising
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  September 22, 2023
  a year ago

• Transaction Date

  February 19, 2025
  5 days ago

• Status Date

  February 18, 2025
  6 days ago

• Published for Opposition Date

  March 11, 2025
  14 days from now

• Location Date

  February 18, 2025
  6 days ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  KURAISHI, KRISTIN

• Attorney Docket Number

  17113.212IB

  Attorney Name

  Andrew S. Ehard

  Law Office Assigned Location Code

  O40

• Owners

  • Telix Pharmaceuticals Limited

Case File Statements

• GS0401: Custom manufacture of pharmaceuticals, namely, radiopharmaceuticals; Custom manufacture of pharmaceuticals, namely, radiolabelling of pharmaceuticals
• DM0000: The mark consists of a four point blue star in the center of a partially closed blue circle that contains openings on the top left and the bottom right. There are three blue shaded circles coming from the top left of the star and the bottom right of the star going out the top left of the circle and the bottom right of the circle in a line. The color white serves as background areas and is not claimed as a feature of the mark.
• GS0051: Chemicals for pharmaceutical use in the nature of chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and diseases associated with cellular proliferation; pharmaceuticals for the treatment of cancer and diseases associated with cellular proliferation; Pharmaceutical preparations for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products, namely, radiopharmaceutical diagnostic preparations and radiopharmaceutical treatment preparations for the treatment of cancer and diseases associated with cellular proliferation; chemicals being radiopharmaceuticals for diagnostic uses; radiopharmaceutical drug preparations for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products for medical use; Diagnostic radiopharmaceutical preparations
• CC0000: The color blue is claimed as a feature of the mark.
• GS0351: Advertising services; business advisory services relating to product development; business consultancy; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialization of goods, namely, procuring of contracts for third parties for the purchase and sale of goods
• GS0011: Radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemicals for use in the manufacture of radiopharmaceutical products; chemical products for radioactive labelling
• GS0451: Exploitation of intellectual property rights, namely, licensing of intellectual property rights; licensing of intellectual property
• GS0101: Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication
• GS0421: Provision of scientific information in the field of pharmaceuticals and clinical trials; scientific and technical analysis, namely, scientific research and analysis in the field of pharmaceuticals; scientific research consultancy; scientific research; scientific research in the field of pharmacy; medical research; research and development of new products; laboratory research relating to pharmaceuticals; advisory services being product development consultation relating to immunological products; research and development of new techniques for radiolabelling of pharmaceutical products

Case File Event Statements

• 2/16/2024 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/20/2024 - 11 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/9/2024 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 2/12/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/14/2024 - 11 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/21/2024 - 11 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/9/2024 - 10 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/9/2024 - 10 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/1/2024 - 9 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 10/7/2024 - 4 months ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/7/2024 - 4 months ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/7/2024 - 4 months ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 1/26/2025 - 29 days ago

  13 - ASSIGNED TO EXAMINER Type: DOCK

• 2/10/2025 - 14 days ago

  14 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/10/2025 - 14 days ago

  17 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/10/2025 - 14 days ago

  15 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/10/2025 - 14 days ago

  16 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 2/14/2025 - 10 days ago

  19 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 2/14/2025 - 10 days ago

  21 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 2/14/2025 - 10 days ago

  18 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 2/14/2025 - 10 days ago

  22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/14/2025 - 10 days ago

  20 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN